• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度南部结核分枝杆菌异烟肼和利福平耐药的遗传决定因素的鉴定和特征分析。

Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India.

机构信息

Department of Biochemistry, University of Cambridge, Tennis Court. Rd., Cambridge, CB2 1GA, UK.

Department of Medicine, University of Cambridge, Hills Rd., Cambridge, CB2 0QQ, UK.

出版信息

Sci Rep. 2019 Jul 16;9(1):10283. doi: 10.1038/s41598-019-46756-x.

DOI:10.1038/s41598-019-46756-x
PMID:31311987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6635374/
Abstract

Drug-resistant tuberculosis (TB), one of the leading causes of death worldwide, arises mainly from spontaneous mutations in the genome of Mycobacterium tuberculosis. There is an urgent need to understand the mechanisms by which the mutations confer resistance in order to identify new drug targets and to design new drugs. Previous studies have reported numerous mutations that confer resistance to anti-TB drugs, but there has been little systematic analysis to understand their genetic background and the potential impacts on the drug target stability and/or interactions. Here, we report the analysis of whole-genome sequence data for 98 clinical M. tuberculosis isolates from a city in southern India. The collection was screened for phenotypic resistance and sequenced to mine the genetic mutations conferring resistance to isoniazid and rifampicin. The most frequent mutation among isoniazid and rifampicin isolates was S315T in katG and S450L in rpoB respectively. The impacts of mutations on protein stability, protein-protein interactions and protein-ligand interactions were analysed using both statistical and machine-learning approaches. Drug-resistant mutations were predicted not only to target active sites in an orthosteric manner, but also to act through allosteric mechanisms arising from distant sites, sometimes at the protein-protein interface.

摘要

耐药性结核病(TB)是全球主要死因之一,主要源于结核分枝杆菌基因组的自发突变。了解突变赋予耐药性的机制对于确定新的药物靶点和设计新药至关重要。先前的研究已经报道了许多赋予抗结核药物耐药性的突变,但几乎没有进行系统分析来了解它们的遗传背景以及对药物靶点稳定性和/或相互作用的潜在影响。在这里,我们报告了对来自印度南部一个城市的 98 例临床结核分枝杆菌分离株的全基因组序列数据的分析。该数据集经过表型耐药性筛选并进行测序,以挖掘赋予异烟肼和利福平耐药性的遗传突变。在异烟肼和利福平分离株中最常见的突变分别是 katG 中的 S315T 和 rpoB 中的 S450L。我们使用统计和机器学习方法分析了突变对蛋白质稳定性、蛋白质-蛋白质相互作用和蛋白质-配体相互作用的影响。耐药性突变不仅预测以正位方式靶向活性位点,而且还通过来自远处位点的变构机制起作用,有时甚至在蛋白质-蛋白质界面处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/415b1777323d/41598_2019_46756_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/cd3c4d9fd95c/41598_2019_46756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/4670ad7b1284/41598_2019_46756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/6e103d036e15/41598_2019_46756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/edf3a8d7b0f6/41598_2019_46756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/532f0e1bddeb/41598_2019_46756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/8863fad9a562/41598_2019_46756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/415b1777323d/41598_2019_46756_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/cd3c4d9fd95c/41598_2019_46756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/4670ad7b1284/41598_2019_46756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/6e103d036e15/41598_2019_46756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/edf3a8d7b0f6/41598_2019_46756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/532f0e1bddeb/41598_2019_46756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/8863fad9a562/41598_2019_46756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba2/6635374/415b1777323d/41598_2019_46756_Fig7_HTML.jpg

相似文献

1
Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India.印度南部结核分枝杆菌异烟肼和利福平耐药的遗传决定因素的鉴定和特征分析。
Sci Rep. 2019 Jul 16;9(1):10283. doi: 10.1038/s41598-019-46756-x.
2
Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.使用基因分型诊断方法无法检测到耐多药结核分枝杆菌的rpoB和katG基因中的突变。
Pan Afr Med J. 2017 Jun 28;27:145. doi: 10.11604/pamj.2017.27.145.10883. eCollection 2017.
3
Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population.印度中北部人群耐多药结核分枝杆菌分离株中katG和rpoB基因的分子建模与对接分析
J Infect Public Health. 2017 Sep-Oct;10(5):593-599. doi: 10.1016/j.jiph.2017.01.005. Epub 2017 Feb 27.
4
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial.通过DNA测序对利福平及异烟肼耐药结核分枝杆菌菌株进行基因分型检测:一项随机试验
Ann Clin Microbiol Antimicrob. 2009 Jan 30;8:4. doi: 10.1186/1476-0711-8-4.
5
Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.缅甸仰光结核分枝杆菌分离株中异烟肼和利福平耐药相关突变:对快速分子检测的意义
J Antimicrob Chemother. 2009 Oct;64(4):694-701. doi: 10.1093/jac/dkp292. Epub 2009 Aug 26.
6
Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.在高负担环境下,将耐药结核病患者的结核分枝杆菌分离株中的基因突变与异烟肼表型耐药水平相关联。
Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2551-2561. doi: 10.1007/s10096-021-04316-0. Epub 2021 Jul 23.
7
Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.对药物治疗前后的结核分枝杆菌分离株进行全基因组纵向分析,揭示了耐药性产生的渐进步骤。
Tuberculosis (Edinb). 2016 May;98:50-5. doi: 10.1016/j.tube.2016.02.004. Epub 2016 Feb 26.
8
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.在吉尔吉斯斯坦的耐利福平及异烟肼结核分枝杆菌中 rpoB、katG、inhA 和 ahp 基因突变。
BMC Microbiol. 2018 Mar 22;18(1):22. doi: 10.1186/s12866-018-1168-x.
9
Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.哈萨克斯坦分离的利福平及异烟肼耐药结核分枝杆菌株的分子特征。
Jpn J Infect Dis. 2011;64(3):253-5.
10
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.在一个耐药结核病发病率较低的国家,表型上对利福平敏感的结核分枝杆菌分离株中出现有争议的 rpoB 突变。
BMC Infect Dis. 2019 Jan 3;19(1):3. doi: 10.1186/s12879-018-3638-z.

引用本文的文献

1
Fast and exact gap-affine partial order alignment with POASTA.使用POASTA进行快速准确的间隙仿射偏序比对。
Bioinformatics. 2024 Dec 26;41(1). doi: 10.1093/bioinformatics/btae757.
2
Tackling the Antimicrobial Resistance "Pandemic" with Machine Learning Tools: A Summary of Available Evidence.使用机器学习工具应对抗微生物药物耐药性“大流行”:现有证据综述
Microorganisms. 2024 Apr 23;12(5):842. doi: 10.3390/microorganisms12050842.
3
Prevalence of mutations associated with isoniazid and rifampicin resistance: A systematic review and -analysis.

本文引用的文献

1
Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis.理解结核分枝杆菌中假定的耐药突变的分子后果。
Sci Rep. 2018 Oct 18;8(1):15356. doi: 10.1038/s41598-018-33370-6.
2
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.基于 DNA 测序的一线抗结核药物敏感性预测。
N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.
3
Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam.
与异烟肼和利福平耐药相关的突变的流行情况:一项系统评价与分析
J Clin Tuberc Other Mycobact Dis. 2023 Jun 1;32:100379. doi: 10.1016/j.jctube.2023.100379. eCollection 2023 Aug.
4
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.结核分枝杆菌的致病机制:对新药研发的启示
Mol Biomed. 2022 Dec 22;3(1):48. doi: 10.1186/s43556-022-00106-y.
5
High-Throughput Variant Detection Using a Color-Mixing Strategy.高通量变异检测的混色策略。
J Mol Diagn. 2022 Aug;24(8):878-892. doi: 10.1016/j.jmoldx.2022.04.015. Epub 2022 Jun 16.
6
Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran.检测并鉴定来自伊朗结核分枝杆菌临床分离株中与异烟肼耐药相关的基因突变。
Mol Biol Rep. 2022 Jul;49(7):6135-6143. doi: 10.1007/s11033-022-07404-2. Epub 2022 Apr 2.
7
Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates-Chennai, India, 2013-2016.全基因组测序以识别结核分枝杆菌分离株中漏检的利福平及异烟肼耐药性——印度金奈,2013年至2016年
Front Microbiol. 2021 Nov 22;12:720436. doi: 10.3389/fmicb.2021.720436. eCollection 2021.
8
Investigating the effect of an identified mutation within a critical site of PAS domain of WalK protein in a vancomycin-intermediate resistant Staphylococcus aureus by computational approaches.采用计算方法研究耐万古霉素中间葡萄球菌 WalK 蛋白 PAS 结构域关键位点鉴定突变的影响。
BMC Microbiol. 2021 Sep 2;21(1):240. doi: 10.1186/s12866-021-02298-9.
9
Label-Free Comparative Proteomics of Differentially Expressed Protein in Rifampicin-Related Drug-Resistant Strains.利福平相关耐药菌株中差异表达蛋白质的无标记比较蛋白质组学
Pathogens. 2021 May 15;10(5):607. doi: 10.3390/pathogens10050607.
10
Structure-Guided Computational Approaches to Unravel Druggable Proteomic Landscape of .用于解析[具体对象]可成药蛋白质组图谱的结构导向计算方法
Front Mol Biosci. 2021 May 7;8:663301. doi: 10.3389/fmolb.2021.663301. eCollection 2021.
越南频繁传播结核分枝杆菌北京家族和对北京型 EsxW 的正向选择。
Nat Genet. 2018 Jun;50(6):849-856. doi: 10.1038/s41588-018-0117-9. Epub 2018 May 21.
4
Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis.pncA 突变分析揭示了结核分枝杆菌各谱系之间非重叠的模式。
Sci Rep. 2018 Mar 15;8(1):4628. doi: 10.1038/s41598-018-22883-9.
5
Patterns of rpoC Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea.从韩国患者中分离出的耐多药结核分枝杆菌中rpoC基因突变模式
Tuberc Respir Dis (Seoul). 2018 Jul;81(3):222-227. doi: 10.4046/trd.2017.0042. Epub 2018 Mar 7.
6
A standardised method for interpreting the association between mutations and phenotypic drug resistance in .一种标准化方法,用于解释 突变与表型药物耐药性之间的关联。
Eur Respir J. 2017 Dec 28;50(6). doi: 10.1183/13993003.01354-2017. Print 2017 Dec.
7
SDM: a server for predicting effects of mutations on protein stability.SDM:一种用于预测突变对蛋白质稳定性影响的服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W229-W235. doi: 10.1093/nar/gkx439.
8
Mycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics.来自印度南部的结核分枝杆菌全基因组序列揭示了新的耐药机制以及对区域特异性诊断的需求。
Clin Infect Dis. 2017 Jun 1;64(11):1494-1501. doi: 10.1093/cid/cix169.
9
Performance of Mycobacterium Growth Indicator Tube BACTEC 960 with Lowenstein-Jensen method for diagnosis of Mycobacterium tuberculosis at Ethiopian National Tuberculosis Reference Laboratory, Addis Ababa, Ethiopia.在埃塞俄比亚亚的斯亚贝巴的埃塞俄比亚国家结核病参考实验室,使用分枝杆菌生长指示管BACTEC 960和罗氏培养基法诊断结核分枝杆菌的性能。
BMC Res Notes. 2017 May 10;10(1):181. doi: 10.1186/s13104-017-2497-9.
10
Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.结核分枝杆菌转录及转录抑制的结构基础
Mol Cell. 2017 Apr 20;66(2):169-179.e8. doi: 10.1016/j.molcel.2017.03.001. Epub 2017 Apr 6.